dalteparin has been researched along with Angioma in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Angioma: A vascular anomaly due to proliferation of blood or lymphatic vessels that forms a tumor-like mass. Vessels in the angioma may or may not be dilated.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Serrano, F | 1 |
Bisdorff-Bresson, A | 1 |
Sroussi, J | 1 |
Aymard, A | 1 |
Wassef, M | 1 |
Civelli, V | 1 |
Boujlel, S | 1 |
Houdart, E | 1 |
Drouet, L | 1 |
1 other study available for dalteparin and Angioma
Article | Year |
---|---|
Giant intrahepatic venous malformation with localized intravascular coagulopathy. Follow-up and treatment during pregnancy.
Topics: Abortion, Habitual; Adult; Anticoagulants; Blood Coagulation Disorders; Cesarean Section; Enoxaparin | 2020 |